Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | OR | 95% CI | p value | OR | 95% CI | p value |
Tumor size | 1.04 | 1.02–1.05 | < 0.001 | 1.12 | 1.10–1.14 | 0.002 |
Non-smooth margin | 1.26 | 1.15–1.37 | < 0.001 | 1.23 | 1.06–1.58 | 0.034 |
Irregular shape | 1.24 | 1.14–1.35 | < 0.001 | 1.03 | 0.86–1.23 | 0.791 |
NAPHE | 1.14 | 0.86–1.50 | 0.453 | |||
Non-peripheral washout | 1.14 | 0.93–1.39 | 0.282 | |||
Enhancing capsule | 0.93 | 0.79–1.10 | 0.478 | |||
Nodule-in-nodule | 1.09 | 0.92–1.30 | 0.386 | |||
Mosaic architecture | 1.19 | 1.09–1.30 | 0.001 | 1.20 | 1.14–1.26 | 0.008 |
Intratumoral blood products | 1.18 | 1.07–1.30 | 0.005 | 0.98 | 0.87–1.10 | 0.757 |
Intratumoral fat content | 1.19 | 1.08–1.30 | 0.003 | 1.04 | 0.92–1.18 | 0.593 |
Mild-moderate T2 hyperintensity | 0.0 | 0–∞ | 1.0 | |||
Corona enhancement | 1.20 | 1.10–1.31 | 0.001 | 0.93 | 0.79–1.10 | 0.49 |
Iron sparing | 0.88 | 0.76–1.02 | 0.156 |